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Hydrogen sulfide regulates 
hippocampal neuron excitability 
via S‑sulfhydration of Kv2.1
Mark L. Dallas 1*, Moza M. Al‑Owais2,5*, Nishani T. Hettiarachchi2, 
Matthew Scott Vandiver3, Heledd H. Jarosz‑Griffiths4, Jason L. Scragg2, John P. Boyle2, 
Derek Steele5 & Chris Peers1,6
Hydrogen sulfide  (H2S) is gaining interest as a mammalian signalling molecule with wide ranging 
effects. S‑sulfhydration is one mechanism that is emerging as a key post translational modification 
through which  H2S acts. Ion channels and neuronal receptors are key target proteins for 
S‑sulfhydration and this can influence a range of neuronal functions. Voltage‑gated  K+ channels, 
including Kv2.1, are fundamental components of neuronal excitability. Here, we show that both 
recombinant and native rat Kv2.1 channels are inhibited by the  H2S donors, NaHS and GYY4137. 
Biochemical investigations revealed that NaHS treatment leads to S‑sulfhydration of the full length 
wild type Kv2.1 protein which was absent (as was functional regulation by  H2S) in the C73A mutant 
form of the channel. Functional experiments utilising primary rat hippocampal neurons indicated 
that NaHS augments action potential firing and thereby increases neuronal excitability. These studies 
highlight an important role for  H2S in shaping cellular excitability through S‑sulfhydration of Kv2.1 at 
C73 within the central nervous system.
Current awareness of the biological roles of endogenous hydrogen sulfide  (H2S) is expanding rapidly, as our 
understanding of its production and cellular targets continue to  develop1–3. Enzymatic production of  H2S from 
cysteine is regulated by cystathionine γ lyase (CSE) and cystathionine β synthetase (CBS). With reference to the 
central nervous system (CNS) 3-mercaptopyruvate sulfurtransferase (3MST) along with cysteine aminotrans-
ferase has also been demonstrated to generate  H2S in the  brain4, 5, with additional  H2S protein-bound sulphur 
“stores”6.  H2S levels in the brain have been reported in the µM  range7, 8, however real time measurements are 
challenging given the physiochemical nature of the  gasotransmitter9–11. While physiological levels are known 
to mediate diverse signalling cascades, there is the potential to develop cellular toxicity however a consensus 
on the molecular basis of  H2S mediated neurotoxicity is  lacking12, 13. Furthermore, some effects of  H2S have 
been demonstrated to occur through polysulfides  (H2Sn) which are important physiological signalling species 
in  themselves14, 15.
In the CNS, the gasotransmitter,  H2S promotes induction of long-term  potentiation7, modifies astrocytic  Ca2+ 
 signalling16 and protects neurons against oxidative  stress17. Given the diversity of effects, it is perhaps surprising 
that one mechanism of action is emerging as vital in regulating these processes; the modification of protein thiol 
groups termed S-sulfhydration, in which the thiol –SH groups in cysteine residues are converted to persulfide 
–SSH  groups1, 18, leading to modulation of protein function and/or protection against oxidation. Such a post-
translational modification is analogous to the widespread S-nitrosylation of diverse proteins by nitric  oxide19. 
Studies have suggested that up to 50% of cellular proteins may be basally S-sulfhydrated1, 18, implying that this 
post-translational modification is of widespread physiological importance.
Ion channels are a significant and expanding family of substrates for regulation by  H2S20. Clear evidence for 
modulation of vascular  KATP channels by S-sulfhydration has been  presented21 and, given the numerous ion 
channels within the CNS that may be modulated by  H2S20, it seems likely (although has yet to be demonstrated) 
that S-sulfhydration may be an important modulatory mechanism within the CNS. Voltage-gated potassium 
channels (Kv) are the most diverse ion channel  family22 and some subfamilies have already been reported as 
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substrates for  H2S23, 24. In the present study, we have investigated the potential modulation of the delayed rectifier 
channel Kv2.1 by  H2S. This channel is unique in that it is regulated through post translational modifications that 
have profound functional consequences. For example, phosphorylation of Kv2.1 dramatically alters excitability 
of central neurons, as has been demonstrated in hippocampal  neurons25–27 suggesting that the mechanisms 
regulating these channels are highly important to signalling within the CNS.
Experimental procedures
HEK293 cell culture. Wild-type and Kv2.1-transfected HEK293 cells (the latter a gift from Dr JS Trim-
mer, Davis, CA) were maintained at 37 °C (95% air:5%  CO2) in DMEM containing 2mM glutamine, 10% fetal 
bovine serum, 1% Glutamax and 1% penicillin/streptomycin28. The Kv2.1 gene (KCNB1) was originally cloned 
from rat. The C29A, C73A and C831A mutations were introduced into WT rat Kv2.1 using the Quik-Change 
Site-Directed Mutagenesis Kit (Stratagene, Cheadle, UK) according to the manufacturer’s instructions. All con-
structs were verified by DNA sequence analysis before transfection. Cells were plated either onto coverslips for 
electrophysiology or utilised for biochemical assays (see below).
Primary neuron culture. Preparation of rodent neuronal cultures was carried out in accordance with local 
University of Leeds regulations, and reported in line with ARRIVE guidelines. Procedures were approved by the 
local University of Leeds ethics committee. Briefly, hippocampi from 6 to 8 day old Wistar rats were removed for 
mechanical and enzymatic dissociation as described  before28. Tissue was incubated (15 min at 37 °C) in phos-
phate buffered saline containing 0.25 μg/ml trypsin (EC 4.4.21.4, from bovine pancreas; Sigma). Trypsin diges-
tion was terminated by the addition of an equal volume of buffer containing 16 μg/ml soy bean trypsin inhibitor 
(SBTI, type I-S; Sigma), 0.5 μg/ml DNaseI (EC 3.1.21.1 type II from bovine pancreas; 125 kU/ml; Sigma) and 1.5 
mM  MgSO4. Following centrifugation (3000 rpm for 5 min), cells were resuspended in minimal Earle’s medium 
(MEM) supplemented with 10% fetal calf serum, 19 mM KCl, 13 mM glucose, 50 IU/ml penicillin and 50 μg/
ml streptomycin. 100 μl of cell suspension was plated onto 10 mm diameter poly-l-lysine coated coverslips 
in a 24-well plate for electrophysiology. After 24 h, this medium was replaced with one containing 10% horse 
serum (in place of fetal calf serum) and 80 μM fluorodexoyurdine (FUDR) to prevent the proliferation of non-
neuronal cells. By 48 h, this medium was exchanged for one containing Neurobasal media, supplemented with 
2% B-27, 1% penicillin/streptomycin, 0.5 mM l-glutamine and 25 μM l-glutamic acid. Cells were maintained 
in a humidified incubator at 37 ºC (95% air: 5%  CO2) for 7 days. All experiments were performed using cells 
cultured for 7 to 14 days.
Electrophysiology. Fragments of coverslip with attached cells were transferred to a perfused (3–5 ml/min) 
recording chamber mounted on the stage of an Olympus CK40 inverted microscope. As previously  described28, 
the standard perfusate for HEK293 cells (pH 7.2, 22 ± 1 °C) was composed of (in mM): NaCl (140), KCl (5), 
 MgCl2 (2), HEPES (10),  CaCl2 (2), and glucose (10). Patch pipettes had resistances 4–6 MΩ. Series resistance 
was monitored after breaking into the whole cell configuration throughout the duration of experiments. If a 
significant increase occurred (> 20%), the experiment was terminated. Series resistance was monitored and com-
pensated for (60–80%) after breaking into the whole cell configuration throughout the duration of experiments. 
The pipette solution (pH 7.2) consisted of (in mM): KCl (140), EGTA (5),  MgCl2 (2),  CaCl2 (1), HEPES (10), 
and glucose (10). For some experiments an anti-Kv2.1 antibody (Neuromab, CA) was added to the intracellular 
solution (final concentration of 0.5 μg/ml). For HEK293 cells, two voltage protocols were adopted: (1) a series of 
depolarising steps from − 100 to + 80 mV in 10 mV increments for 500ms, (2) a single step to + 50 mV from − 70 
mV for 100 ms at 0.2 Hz. For hippocampal neurons, similar protocols were used except for the inclusion of a sin-
gle 30 ms prepulse to − 50 mV, to inactivate ‘A’-type potassium currents. Signals were sampled at 10 kHz and low 
pass filtered at 2 kHz. To investigate neuronal excitability, current-clamp recordings were undertaken. Action 
potential recordings were made in whole-cell current-clamp mode with signals low-pass filtered at 2 kHz and 
sampled at 10 kHz. Action potentials were evoked by 500 ms current pulses (0–200 pA). The perfusate consisted 
of (in mM): NaCl (135), KCl (5),  CaCl2 (2.5),  MgCl2 (1.2), HEPES (5), and glucose (10), and was bubbled with 
mixed gas (95% air/5%  CO2; pH 7.4). Intracellular solution (pH 7.2) consisted of (in mM): KGluconate (110), 
NaCl (10), EGTA (11),  Na2ATP (2),  MgCl2 (2),  CaCl2 (0.1), NaGTP (0.3), and HEPES (10). Voltage- and current-
clamp analysis protocols were performed using an Axopatch 200A amplifier/Digidata 1200 interface controlled 
by Clampex 9.0 software (Molecular Devices, Foster City, CA). Offline analysis was performed using Clampfit 
9.0 (Molecular Devices, Foster City, CA). Conductance values (G) were calculated as previously  described27. 
Results are presented as means ± S.E.M., and statistical analysis performed using unpaired Student’s t-tests where 
P < 0.05 was considered statistically significant.
Modified biotin switch assay. The assay was carried out as described  previously18 but with some modifi-
cations: HEK293 cells expressing Kv2.1 WT or C73A mutant were cultured at 37 °C in a humidified atmosphere 
containing 95% air and 5%  CO2 and treated with 250 µM NaHS for 1 h or 2 h when 90% confluent. Untreated 
cells were used as a controls. Cells were homogenized in non-denaturing lysis buffer (Tris-HCl 50 mM; NaCl 
300 mM; EDTA 5 mM; Triton X-100 1%) unless stated otherwise all buffers were supplemented with complete 
cocktail protease inhibitors tablets (Life Science Roche, UK). Lysate was collected via centrifugation at 13,000 
g (10 min at 4 °C). Protein concentration was determined using Pierce BCA Protein Assay Kit (Thermo Fisher 
Scientific, UK) according to the manufacturer’s instructions. To block free cysteines, lysates (250 μg total pro-
tein) were added to blocking buffer (HEPES 250 mM, pH 7.7; EDTA 1 mM plus 25% SDS and 20 mM methyl 
methanethiosulfonate [MMTS]) and incubated at 50 °C for 20 min with constant shaking at 1400 rpm. The sam-
ples were buffer exchanged and MMTS was removed using protein desalting spin columns (Thermo scientific, 
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UK). Biotin-N-[6-(biotinamido)hexyl]-3′-(2′-pyridyldithio) propionamide (HPDP) was added to the buffer 
exchanged protein samples a to a final concentration of 4 mM and incubated in the dark for 90min at room 
temperature with constant shaking (1400 rpm), biotinylated proteins were then buffer exchanged using spin col-
umns to remove biotin–HPDP in the neutralization buffer (HEPES 20 mM; NaCl 100 mM; EDTA 1 mM Triton 
X-100 0.5%, pH 7.7) and precipitated by streptavidin-agarose beads, for 16 h at 4 °C. The biotinylated proteins 
were eluted by SDS-PAGE sample buffer and subjected to Western blot analysis.
Anti-Kv2.1 antibodies K89/34 (NeuroMab, Davis, CA) were used to detect Kv2.1 WT and C73A. β-Actin was 
used as loading control (Sigma-Aldrich, UK). ImageJ software (NIH, Bethesda, USA) was used to analyse band 
intensities for Kv2.1 before and after the assay.
Hydrogen sulfide generation. Hydrogen sulfide  (H2S) was produced using the donor molecule sodium 
hydrosulfide (NaHS, Sigma-Aldrich, UK) and made up as a stock solution in Hank’s Balanced Salt Solution. This 
stock was then diluted in the perfusate to give the working concentration as stated in the text. To avoid degra-
dation and loss of  H2S the stocks were routinely made up immediately prior to experimentation. In addition, 
to confirm a role for  H2S, the  H2S-slow releasing molecule P-(4-methoxyphenyl)-p-4-morpholinylphosphino-
dithioic acid morpholine salt (GYY4137; Sigma-Aldrich, UK) was used. GYY4137 (1 M stock) was dissolved in 
DMSO and stored at − 80 °C, on the day of experiments the stock was diluted to 100 mM in perfusate and used 
on the same day, the final concentration of DMSO in the bath did not exceed 0.001%, when higher GYY4137 
concentrations were used a 20 mM stock was made fresh in PBS and used on the same day for these experiments.
Results
To examine whether Kv2.1 could be regulated by  H2S, we firstly recorded whole-cell currents from HEK293 
cells stably expressing recombinant Kv2.1, as previously  described28. Bath application of the  H2S donor, NaHS 
(20 μM-1 mM), inhibited currents flowing through Kv2.1 channels in a concentration-dependent manner 
(Fig. 1A,B,C). Currents were inhibited at all activating test potentials (Fig. 1B) and there was no significant 
effect of NaHS on whole-cell conductance (Fig. 1C), suggesting that inhibition of current amplitudes was not 
attributable to altered gating. Inhibition of Kv2.1 currents was largely irreversible upon washout (e.g. Fig. 1E; 
23.5 ± 4.1% recovery after 10 min, n = 12). However, current amplitudes could be recovered to near pre-NaHS 
treatment levels by exposure to the reducing agent dithiothreitol (DTT, 1 mM; Fig. 1F, 83.4 ± 3.7% recovery, 
n = 13). Similar results were obtained using another  H2S donor molecule GYY4137 (Fig. 2). Kv2.1 currents at 
test potentials greater than + 40 mV by 30 µM GYY4137 (Fig. 2A,B), this concentration was determined fol-
lowing a dose-response relationship for the effects of the  H2S donor GYY4137 (Fig. 2D). Normalized current 
amplitudes was inhibited by 40.1 ± 8.2%, n = 15, measured at + 50 mV and this inhibition was irreversible upon 
washout (Fig. 2C).
Reversal of  H2S inhibition of Kv2.1 by DTT suggested a possible involvement of redox regulation of the chan-
nel protein. Sesti and  colleagues29 have demonstrated that cysteine 73 is crucial to the response of this channel to 
oxidation, and so we generated a C73A mutant to explore the role of this residue in  H2S regulation. As exempli-
fied in Fig. 3A, and quantified in Fig. 3B, NaHS was without effect on the C73A mutant, whilst wild-type chan-
nels, studied in parallel, were significantly inhibited. Kv2.1 protein has an array of modifiable cysteine residues, 
some of which are not sensitive to oxidative  modification29. To determine a role for other cystine residues in the 
observed NaHS effect, we generated several other mutant cell lines. C29A and C831A still provided functional 
channels however both cell lines were sensitive to inhibition following application of 250 μM NaHS (C831A by 
20 ± 2% (n = 6); C29A by 26.4 ± 4% (n = 5), (Fig. 3C,D).
Many of the diverse effects of  H2S in different systems arise due to specific, direct modulation of target proteins 
by S-sulfhydration (i.e. the conversion of –SH groups in cysteine residues into –SSH groups). S-sulfhydration 
is detectable via by the modified biotin switch  assay18, and this approach was taken with the recombinant Kv2.1 
protein. As illustrated in Fig. 4A, NaHS did indeed S-sulfhydrate recombinant Kv2.1, evident from 30 mins, 
suggesting that the mechanism of channel inhibition was due to direct protein modification (full blots can be 
found as Supplementary Figures S1, 2 online). This was supported by the observation that the C73A mutant form 
of the channel appeared resistant to this form of post-translational modification (Fig. 4A; full blots available as 
Supplementary Figure S3 online). To provide a level of quantification 50.8 ± 7.5%, (n = 3) of WT Kv2.1 channel 
protein (Fig. 4B) can be identified as S-sulfhydrated after 2 h treatment with NaHS (250 µM) following modified 
biotin switch assay (time dependence further explored in Supplementary Figure S4 online). The time discrepan-
cies observed between functional and biochemical experimentation are likely to reflect technical limitations of 
single cell versus population studies. The combination of these methodologies has been extensively used when 
examining post-translational modifications of plasma membrane proteins.
Kv2.1 is widely expressed in the CNS, and its ability to control the firing pattern of hippocampal neurons 
in particular has been described in detail (reviewed in Ref.25). As with HEK293 cells, we employed whole-cell 
patch-clamp recordings to demonstrate that NaHS caused significant inhibition of  K+ currents in hippocampal rat 
neurons (Fig. 5A,B), at all activating test potentials studied. As was the case for recombinant Kv2.1, NaHS-medi-
ated inhibition of  K+ current amplitudes in hippocampal neurons could be recovered by DTT (1 mM; Fig. 5C).
Numerous different voltage-gated  K+ currents contribute to the whole-cell  K+ current in these cells. We and 
others have previously demonstrated that the contribution to the whole-cell current by Kv2.1 can be determined 
by intracellular dialysis (via the patch pipette) of an anti-Kv2.1  antibody28, 30. In agreement with our earlier stud-
ies, intracellular dialysis with this antibody reduced current amplitudes by around 50% (Fig. 5D). Subsequent 
exposures to NaHS (100 µM) did not significantly reduce currents further (Fig. 5D), indicating that NaHS was 
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Kv2.1 channel activity is a major determinant of hippocampal neuronal excitability, and can be dramatically 
modified, for example, by  phosphorylation25, 26. To investigate whether  H2S could alter hippocampal excitability, 
we employed current-clamp recordings. Application of NaHS caused a modest yet significant depolarization of 
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Figure 1.  NaHS inhibits recombinant Kv2.1. (A) Families of currents evoked in a HEK293 cell stably expressing 
Kv2.1 before and during exposure to NaHS (200 μM). Currents were evoked by step-depolarizations, applied 
up to + 80 mV in 10 mV increments from a holding potential of − 70 mV. Scale bars apply to both families of 
currents. (B) Mean (± s.e.m.) current–density versus voltage relationships obtained in 17 cells before (solid 
circles) and during (open circles) exposure to NaHS (200 μM). (C) Mean (± s.e.m., each point taken from 5 to 7 
cells) concentration–response relationship illustrating the effects of NaHS on Kv2.1. Inhibition was determined 
using currents evoked by step-depolarizations from − 70 to + 50 mV). (D) Plot of voltage-dependence of 
activation of Kv2.1 before (solid circles) and during (open circles) exposure to NaHS (200 μM). Data are 
means ± s.e.m. Curves were obtained by fitting data to the sigmoidal Boltzmann function. (E) Example time-
series plot illustrating normalized current amplitudes evoked by step-depolarizations from − 70 to + 50 mV in a 
Kv2.1-expressing HEK293 cell. For the period indicated by the horizontal bar, NaHS (200 μM) was applied via 
the perfusate. (F) as (E), except that, following washout of NaHS, the cell was exposed to dithiothreitol (DTT, 
1 mM) for the period indicated by the second horizontal bar. Inset shows example currents under the conditions 
indicated (DTT applied after washout of NaHS). Scale bars: 2 nA (vertical) and 10 ms (horizontal).
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cells (9.1 ± 1.8 mV, n = 6, P < 0.01), indicative of reported  H2S effects on TRP channels in dorsal root ganglion 
 neurons31. This effect was compensated by current injection, in order to examine the effects of depolarizing 
current injections in cells with a standardised membrane potential of − 70 mV (Fig. 5A,B). Square wave current 
injections evoked action potentials which increased in frequency with increasing current amplitude (Fig. 5A,B). 
In the presence of NaHS (200 µM), action potential frequency was augmented, particularly following larger cur-
rent injections, as anticipated when Kv2.1 channels participate in neuronal excitability.
Discussion
Our study identifies  H2S as another important modulator of the voltage-gated  K+ channel Kv2.1. This chan-
nel is highly expressed in the cortex and hippocampus where it is a major determinant of intrinsic neuronal 
excitability through a diverse complement of signalling cascades. High levels of constitutive phosphorylation 
determine the voltage-dependence of gating and location of Kv2.1, and both factors can influence neuronal excit-
ability in a dynamic  manner25, 32, 33. Activity-dependent, calcineurin-mediated dephosphorylation of Kv2.1 can 
suppress  excitability33, and rapid rephosphorylation (e.g. via  CDK534) can restore excitability. However, this is 
dependent on the location of the phosphorylation site within the channel protein: for example, AMP-activated 
protein kinase-mediated phosphorylation at distinct residues (S440 and S537) can suppress excitability and 
exert hyperpolarizing shifts in the voltage-dependent activation, similar to calcineurin-mediated dephospho-
rylation of other  residues27. In addition to alteration of gating via phosphorylation, Kv2.1 channel inhibition 





























































Figure 2.  GYY4137 inhibits recombinant Kv2.1. (A) Families of currents evoked in a HEK293 cell 
stably expressing Kv2.1 before and during exposure to GYY4137 (30 μM). Currents were evoked by step-
depolarizations, applied up to + 80 mV in 10 mV increments from a holding potential of -70 mV. Scale bars 
apply to both families of currents. (B) Mean (± s.e.m.) current–density versus voltage relationships obtained in 
11 cells before (solid circles) and during (open circles) exposure to GYY4137 (30 μM). Significance: *P < 0.05; 
**P < 0.01 as compared with controls. (C) Example time-series plot illustrating normalized current amplitudes 
evoked by step-depolarizations in a Kv2.1-expressing HEK293 cell. For the period indicated by the horizontal 
bar, GYY4137 (30 µM) was applied via the perfusate, indicated by horizontal bar, followed by washout. Inset 
shows example currents under the different experimental conditions scale bars: 2 nA (vertical) and 10 ms 
(horizontal). (D) Mean (± s.e.m., each point taken from 3 to 5 cells) concentration–response relationship fitted 
to sigmoidal Boltzmann function illustrating the effects of GYY4137 on Kv2.1. Inhibition was determined using 
currents evoked by step-depolarizations from − 70 to + 50 mV.
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(e.g. following antisense knockdown) also increases high frequency  excitability35, 36. The present study indicates 
that this phenomenon also occurs because of channel inhibition by  H2S (Fig. 3). Thus, using larger depolar-
izing current injections, action potential frequency was augmented by  H2S, suggesting that this gasotransmitter 
may influence excitability physiologically through modulation of Kv2.1 selectively. It remains to be determined 
if polysulfides mediated this inhibition as has been reported for Kv1.4 and Kv3.423. This is likely to be medi-
ated via S-sulfhydration of the channel given our biochemical evidence. There are time discrepancies between 
the acute exposure in the functional recordings and the biochemical observations, but these are comparable 
to other reports of ion channel post-translational modification (see Ref.18). This likely reflects the number of 
S-sulfhydrated channels required to produce a functional effect versus the amount of S-sulfhydrated protein 
detected via our biochemical experimentation.
Such complex regulation of a single channel target suggests it is of fundamental importance to the excitability 
of neurons in which it is expressed, but the fact that it is also a target for modulation by gasotransmitters supports 
the belief that it has even greater physiological significance. While evidence exists that other Kv channels are 
modulated by  H2S, such as  Kv724, 37, 38, the neuronal localisation of these channels will ultimately determine their 
influence on action potential dynamics. For example, Kv7 activation via NaHS has been reported to suppress 
neuropathic  pain24, indicative of a decrease in network  excitability39. These studies have implicated the  H2S in the 



















































































Figure 3.  H2S does not inhibit Kv2.1 C73A but inhibit other recombinant mutant forms. (A) Bar graph 
showing normalised mean (± s.e.m.) effect of NaHS in wild-type (WT), C73A, C29A and C831A mutants 
of Kv2.1, as indicated (**indicates P < 0.01 and ***indicates P < 0.001 with the number of cells tested in 
parentheses). (B) Example time-series plot illustrating normalized current amplitudes evoked by step-
depolarizations from − 70 to + 50 mV in a C73A Kv2.1-expressing HEK293 cell. For the period indicated by the 
horizontal bar, NaHS (250 µM) was applied via the perfusate. Inset shows example currents before and during 
NaHS application, as indicated. (C) Example time-series plot as in (B) for C29A Kv2.1-expressing HEK293 cell. 
For the period indicated by the horizontal bar, NaHS (250 µM) was applied via the perfusate, with irreversible 
effect upon washout for the time period indicated by the horizontal bar. Inset shows example currents before 
and during NaHS application for C29A, as indicated. (D) Same as in (B and C) except the example time-series 
plot illustrating a C831A Kv2.1-expressing HEK293 cell before and during application of NaHS (250 µM) for 
the period indicated by the horizontal bar, as in (C) the effect was irreversible upon washout, indicated by the 
horizontal bar. Inset shows example currents before and during NaHS application for C831A. Scale bars: 0.5 nA 
(vertical) and 50 ms (horizontal).
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by  H2S and also raises questions over  selectivity20. With respect to the hippocampus, Kv7 channels has been 
localised to the axonal initial  segment40 in contrast Kv2.1 channels display a predominant somatodendritic  loci41. 
Therefore, discrete localisation of Kv  channels42, 43 may underpin the respective action of  H2S on neuronal output.
Kv2.1 has also been proposed to play a vital role in oxidative stress-induced apoptosis of central neurons: 
oxidants can initiate apoptosis in a  Zn2+-dependent manner which leads to co-ordinated, Src kinase-mediated 
phosphorylation of the channel protein at an N-terminal tyrosine (Y124) together with p38 MAPK-mediated 
phosphorylation at a C-terminal site (S800). This in turn leads to rapid channel insertion into the plasma mem-
brane; the resultant loss of cytosolic  K+ triggers caspase activation and apoptosis. The present study suggests  H2S 
may provide protection against oxidant-induced apoptosis via inhibition of Kv2.1. Indeed, we have previously 
shown that Kv2.1 is inhibited by carbon monoxide (CO), which is derived from heme oxygenases (HO-1 and 
HO-2). The inducible heme oxygenase, HO-1, is upregulated by numerous stress factors and its ability to provide 




Kv2.1 C73A                  Kv2.1 WT
NaHS (250 µM) NaHS (250 µM)












































Figure 4.  Kv2.1 sensitivity to NaHS is mediated by cysteine 73. (A) S-sulfhydration of WT but not C73A Kv2.1 
by NaHS (250 µM) in HEK293 cells as detected by western blot analysis of biotinylated proteins produced by the 
modified biotin switch assay (upper bands). Middle bands demonstrate Kv2.1 protein input. Lower bands shows 
the loading control β-actin. Representative of five experimental repeats. (B) % fraction of S-sulfhydrated Kv2.1 
following modified biotin switch assay over a 2 h period.
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to inhibit Kv2.128. Interestingly, a similar Kv2.1-mediated protective mechanism may be active in some forms 
of cancer (in which resistance to apoptosis is a hallmark feature of the  disease44) where HO-1 expression is 
constitutively  high45.
Interestingly, research indicates that oxidative stress can modify Kv2.1 channels via a novel means, causing 
their oligomerization through formation of disulfide bridges with adjacent channel proteins. This in turn leads 
to channel clustering and promotion of  apoptosis29, and it was proposed that this is an important aspect of both 
normal, age-related loss of neuronal function which is exacerbated in Alzheimer’s  disease29. Animal studies also 
highlight modulation of the Kv2.1 protein function, to increase hippocampal neuronal excitability, in the 3xTg-
AD model of Alzheimer’s  disease46. In this regard, channel inhibition by  H2S may be of particular importance: 
the modified biotin switch assay revealed that  H2S caused S-sulfhydration of the channel protein (Fig. 2C), and 
this has been proposed to provide protection of vulnerable cysteine residues against  oxidation1. This could have 
implications for cognitive decline and supports the use of  H2S donors to modulate Alzheimer’s  pathology47–49 
however further consideration of the temporal profile of pathology alongside  H2S administration is required.
In summary, we have shown that  H2S inhibits both recombinant and native Kv2.1 and propose that this occurs 
via S-sulfhydration of the channel protein. This occurred in a concentration dependent manner; however, we 
cannot rule out the interactions of other proposed S-sulfhydrated molecular targets on our neuronal observa-
tions. However, consistent with the known physiological role of Kv2.1, we show that  H2S-mediated inhibition 
contributes to augmentation of higher rates of evoked action potential frequencies with the Kv2.1 protein acting 
as a molecular  rheostat50. This has implications for pathological conditions where (i)  H2S production is altered 
(e.g.  dementia51) or (ii) where the Kv2.1 protein has been oxidised at C73 (e.g.  ageing29). Future studies will 
determine whether S-sulfhydration of Kv2.1 will provide protection against apoptosis arising from oxidative 
stress, for example, because of aging or neurodegenerative diseases.
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